DALLA VOLTA, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 154
EU - Europa 101
AS - Asia 95
Totale 350
Nazione #
US - Stati Uniti d'America 153
SG - Singapore 38
IT - Italia 33
CN - Cina 27
FI - Finlandia 20
DE - Germania 18
HK - Hong Kong 16
RU - Federazione Russa 9
TR - Turchia 9
GB - Regno Unito 6
UA - Ucraina 6
ID - Indonesia 3
IE - Irlanda 3
CZ - Repubblica Ceca 2
BE - Belgio 1
CA - Canada 1
FR - Francia 1
IN - India 1
KH - Cambogia 1
LT - Lituania 1
NL - Olanda 1
Totale 350
Città #
Singapore 32
Ashburn 19
Helsinki 19
Houston 17
Hong Kong 16
New York 16
Seattle 10
Istanbul 9
Fairfield 8
Boardman 7
Los Angeles 7
Romola 7
Brescia 6
Munich 6
Beijing 5
Chandler 5
Dalmine 5
Jacksonville 5
Moscow 5
Shanghai 5
Ann Arbor 3
Cambridge 3
Dublin 3
Jakarta 3
London 3
Mantova 3
Wilmington 3
Woodbridge 3
Highland 2
Nanjing 2
Pisogne 2
Princeton 2
Shenyang 2
Washington 2
Brno 1
Brussels 1
Chiswick 1
Clifton 1
Falkenstein 1
Iseo 1
Lappeenranta 1
Leipzig 1
Norwalk 1
Olomouc 1
Phnom Penh 1
San Mateo 1
Sant'anastasia 1
Southwark 1
Tianjin 1
Toronto 1
Villa di Briano 1
Wuxi 1
Totale 263
Nome #
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 130
Gonadal Function in Male Patients With Metastatic Renal Cell Cancer Treated With Sunitinib 46
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 32
Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question 29
Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation 29
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients 21
Resistance to hormonal therapy in prostate cancer 20
Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis 14
null 13
Whole-body Diffusion-weighted Magnetic Resonance Imaging for Assessment of the Bone Response Rate in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Enzalutamide 13
Fat Fraction Extracted from Whole-Body Magnetic Resonance (WB-MR) in Bone Metastatic Prostate Cancer: Intra- and Inter-Reader Agreement of Single-Slice and Volumetric Measurements 12
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study 10
Totale 369
Categoria #
all - tutte 3.357
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.357


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 0 0 0 3 2 3 3 8 1 2
2020/202115 0 2 1 2 0 1 1 1 3 1 3 0
2021/20227 0 1 0 0 0 0 1 1 0 1 1 2
2022/202331 2 1 1 5 3 6 1 4 4 1 1 2
2023/2024125 7 5 16 11 5 30 3 6 17 6 0 19
2024/2025119 4 7 7 51 29 21 0 0 0 0 0 0
Totale 369